Amylyx Pharmaceuticals, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$546Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
1,125clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Sabrina Paganoni | Charlestown, MA | Physical Medicine & Rehabilitation | $73,636.13 |
| Gary Pattee | Lincoln, NE | Neurology (Psychiatry & Neurology) | $58,974.68 |
| Jeffrey Rosenfeld | Fresno, CA | Neuromuscular Medicine (Psychiatry & Neurology) | $36,081.21 |
| Lauren Brown | Portland, OR | Gerontology (Nurse Practitioner) | $26,062.11 |
| Richard Bedlack | Durham, NC | Neurology (Psychiatry & Neurology) | $21,779.53 |
| Bernhardt Zeiher | Port Clinton, OH | $21,518.91 | |
| John Novak | Westerville, OH | Clinical Neurophysiology | $19,798.65 |
| Said Beydoun | Los Angeles, CA | Clinical Neurophysiology | $16,445.44 |
| Michael Elliott | Seattle, WA | Neurology (Psychiatry & Neurology) | $15,541.94 |
| Nithya Mathai | Boynton Beach, FL | Nurse Practitioner | $13,693.60 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.